Levi Strauss heads into August with a quiet but persistent tension: short sellers are rebuilding positions just as insiders — including the CFO — have been trimming in size.
The insider picture is the most striking angle this week. CFO Harmit Singh sold just over 474,000 shares across four transactions on July 23, collecting roughly $11.6 million in aggregate proceeds near the $24 mark. Chief Commercial Officer Gianluca Flore added a further $677,000 sale on July 29. Zoom out over the past 90 days and net insider selling totals approximately $46.4 million — a meaningful clip for a stock trading around $24. The Haas family, which controls the company through intergenerational holdings still above 40% of shares, also trimmed in June, with Robert Haas and related entities selling close to $16.7 million combined. None of these disposals are crisis signals on their own — executives sell for many reasons — but the breadth and timing, right after a strong guidance raise, is worth noting.
Short interest has moved in the same direction as the insiders. Shorts added around 5.4% to their position over the past week, lifting the short interest to roughly 6.4% of the free float. That's the highest level since late June. The rebuild is notable because it reversed a steady decline from a peak near 9.9 million shares short on July 22 — a reading that coincided with the post-earnings selloff following the July 8 print — down to approximately 6.0 million by July 31, before turning back up this week. Despite the short interest pickup, the lending market offers no reinforcement for the bear case. Availability is extremely loose at roughly 1,940% — meaning there are nearly twenty times as many shares available to borrow as there are shares currently borrowed. Cost to borrow has risen 39% over the week to 0.51%, but in absolute terms that remains trivially cheap. The borrow market is not stressed; shorts can add freely and are doing so.
The Street is more mixed than the rebuilding short interest implies. JP Morgan's Matthew Boss raised his target from $33 to $34 on August 4 while maintaining an Overweight — the freshest bellwether move and a constructive one. But Wells Fargo downgraded to Equal-Weight on July 28, keeping its $25 target unchanged, a signal that at least one major firm sees the stock as fairly valued at current levels. The mean analyst target sits at $28.27, implying roughly 16% upside from $24.41, with most firms still clustered in the Outperform/Buy camp after a wave of modest target raises followed the July earnings beat. Valuation is modest: the PE multiple is running near 14.8x and EV/EBITDA around 9.9x, both drifting lower over the past month. The bull case rests on DTC momentum, non-denim expansion, and the premium Blue Tab brand driving margin expansion toward the company's $10 billion sales target. The bear case is simpler: denim softness in the Americas is real, the stock has essentially flatlined over the past month, and forward EPS growth expectations rank in just the 7th percentile of the universe — the weakest factor score in the profile by a wide margin.
Options positioning underscores the cautious tone without amplifying it. The put/call ratio is running at 1.31, roughly in line with its 20-day average of 1.30 and only marginally above neutral on a z-score basis. What's more telling is the directional shift in recent weeks: the PCR peaked at 1.48 on July 20 — the 52-week high — right into earnings, and has since declined as the defensive bid faded. The current reading is not stretched, but it has stayed structurally elevated relative to where it was before mid-July, suggesting options traders still carry a mild hedging bias even after the earnings event passed.
Among closest peers, LULU led the group with an 8.2% weekly gain while VFC added 4.7%. LEVI's flat week — down 0.45% — looks like underperformance in that context. COLM and CPRI were both lower on the week by 3-4%, so it's a split picture within apparel, but the stronger names ran while LEVI drifted.
The next catalyst is the Q3 earnings print scheduled for October 6. Between now and then, the key thread to watch is whether the short interest rebuild continues to accelerate — and whether insider selling at the $24-$25 level persists — or whether the JP Morgan target raise at $34 attracts fresh long-side conviction at current prices.
See the live data behind this article on ORTEX.
Open LEVI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
